zevra_inline_fullcolor_rgb_12in@300ppi (1).png
Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at SLEEP 2024 Annual Meeting
June 03, 2024 11:00 ET | Zevra Therapeutics
KP1077 was well tolerated and showed meaningful clinical improvements in patient-reported assessments of daytime sleepiness, sleep inertia, and brain fog Additional data presented on...
VelocityEHS_Wordmark_CMYK.jpg
VelocityEHS Double Winner in Occupational Health & Safety 2021 Industrial Hygiene Awards
April 15, 2021 09:25 ET | VelocityEHS
CHICAGO, April 15, 2021 (GLOBE NEWSWIRE) -- VelocityEHS, the global leader in cloud-based environment, health, safety (EHS) and sustainability software, announced it has won Platinum Awards in two...